Skip to main content
Clinical Trials/NL-OMON31821
NL-OMON31821
Recruiting
Not Applicable

Continuous Glucose Monitoring System in patients with Cystic Fibrosis - CGMS in CF

HagaZiekenhuis0 sites18 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Cystic fibrosis and diabetes
Sponsor
HagaZiekenhuis
Enrollment
18
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Observational invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. Cystic fibrosis
  • 2\. \> 18 years

Exclusion Criteria

  • 1\. Exocrine pancreas sufficiency
  • 2\. Former Cystic fibrosis\-related diabetes diagnosis
  • 3\. Organ transplants
  • 4\. Pregnancy
  • 5\. Use of medication interfering with glucose tolerance
  • 6\. Recent pulmonary exacerbation, requiring antibiotic therapy within past 4 weeks
  • 7\. Too short follow\-up period of CGMS (\< 24 hours)

Outcomes

Primary Outcomes

Not specified

Similar Trials